Agendia, Inc
Agendia, Inc., based in Irvine, California, specializes in genomic testing for breast cancer, providing actionable insights to tailor treatment plans for patients. Their platforms, including MammaPrint and BluePrint, are designed to enhance understanding of breast cancer biology and support clinicians in making informed decisions regarding under- and over-treatment.
With a commitment to improving patient outcomes, Agendia leverages landmark studies and ongoing trials to validate their testing services, ensuring they remain trusted by leading physicians and healthcare institutions worldwide. The company also emphasizes patient advocacy, engaging with artists and communities to raise awareness about the impact of breast cancer.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.



